paliperidone
Selected indexed studies
- Paliperidone Use in Child Psychiatry: Evidence or Diffidence? (Pharmacology, 2019) [PMID:31096228]
- Paliperidone for schizophrenia. (Am J Health Syst Pharm, 2008) [PMID:18281731]
- Paliperidone extended-release in the short- and long-term treatment of schizophrenia. (Riv Psichiatr, 2019) [PMID:30985829]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Paliperidone Use in Child Psychiatry: Evidence or Diffidence? (2019) pubmed
- Paliperidone for schizophrenia. (2008) pubmed
- Paliperidone extended-release in the short- and long-term treatment of schizophrenia. (2019) pubmed
- The development of paliperidone nanocrystals for the treatment of schizophrenia. (2024) pubmed
- Paliperidone-Associated Sialorrhea: A Case Report With Review of Current Literature. (2022) pubmed
- Paliperidone palmitate in short- and long-term treatment of schizophrenia. (2019) pubmed
- Paliperidone and Edema. (2022) pubmed
- A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia. (2022) pubmed
- Paliperidone for the treatment of schizoaffective disorder. (2016) pubmed
- The preclinical discovery and development of paliperidone for the treatment of schizophrenia. (2020) pubmed